TGN-020 has demonstrated a reduction in AQP4 polarization in neurodegenerative disease models, including Alzheimer’s disease and Parkinson’s disease [24, 25], thereby exacerbating glymphatic dysfunctions in which Aβ metabolism plays a crucial role. Here, AQP4 is linked to Parkinson disease.